These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 33319682)
1. Development and Optimization of Luliconazole Nanostructured Lipid Carriers Based Gel by Quality by Design its Skin Distribution Studies, Dermatokinetic Modeling & In-Vitro and Ex-Vivo Correlation. Bhargav E; Reddy YP; Koteshwara KB Curr Drug Deliv; 2021; 18(7):1041-1053. PubMed ID: 33319682 [TBL] [Abstract][Full Text] [Related]
2. Dermatokinetic assessment of luliconazole-loaded nanostructured lipid carriers (NLCs) for topical delivery: QbD-driven design, optimization, and in vitro and ex vivo evaluations. Mahmood A; Rapalli VK; Gorantla S; Waghule T; Singhvi G Drug Deliv Transl Res; 2022 May; 12(5):1118-1135. PubMed ID: 33895936 [TBL] [Abstract][Full Text] [Related]
3. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s). Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192 [TBL] [Abstract][Full Text] [Related]
4. Topical nanostructured lipid carrier gel of quercetin and resveratrol: Formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer. Imran M; Iqubal MK; Imtiyaz K; Saleem S; Mittal S; Rizvi MMA; Ali J; Baboota S Int J Pharm; 2020 Sep; 587():119705. PubMed ID: 32738456 [TBL] [Abstract][Full Text] [Related]
5. Design and dermatokinetic evaluation of Apremilast loaded nanostructured lipid carriers embedded gel for topical delivery: A potential approach for improved permeation and prolong skin deposition. Rapalli VK; Sharma S; Roy A; Singhvi G Colloids Surf B Biointerfaces; 2021 Oct; 206():111945. PubMed ID: 34216849 [TBL] [Abstract][Full Text] [Related]
6. Formulation design and optimization of cationic-charged liposomes of brimonidine tartrate for effective ocular drug delivery by design of experiment (DoE) approach. Soni PK; Saini TR Drug Dev Ind Pharm; 2021 Nov; 47(11):1847-1866. PubMed ID: 35484943 [TBL] [Abstract][Full Text] [Related]
8. Luliconazole-loaded nanostructured lipid carriers for topical treatment of superficial Tinea infections. Baghel S; Nair VS; Pirani A; Sravani AB; Bhemisetty B; Ananthamurthy K; Aranjani JM; Lewis SA Dermatol Ther; 2020 Nov; 33(6):e13959. PubMed ID: 32618400 [TBL] [Abstract][Full Text] [Related]
9. Development of Oral Lipid Based Nano-formulation of Dapagliflozin: Optimization, in vitro Characterization and ex vivo Intestinal Permeation Study. Zafar A J Oleo Sci; 2020; 69(11):1389-1401. PubMed ID: 33132278 [TBL] [Abstract][Full Text] [Related]
10. Bilosomes as Promising Nanovesicular Carriers for Improved Transdermal Delivery: Construction, in vitro Optimization, ex vivo Permeation and in vivo Evaluation. Ahmed S; Kassem MA; Sayed S Int J Nanomedicine; 2020; 15():9783-9798. PubMed ID: 33324052 [TBL] [Abstract][Full Text] [Related]
11. Development of Soft Luliconazole Invasomes Gel for Effective Transdermal Delivery: Optimization to In-Vivo Antifungal Activity. Kumari S; Alsaidan OA; Mohanty D; Zafar A; Das S; Gupta JK; Khalid M Gels; 2023 Aug; 9(8):. PubMed ID: 37623081 [TBL] [Abstract][Full Text] [Related]
12. Optimized Ribociclib nanostructured lipid carrier for the amelioration of skin cancer: Inferences from Aldawsari MF; Kamal MA; Balaha MF; Jawaid T; Jafar M; Hashmi S; Ganaie MA; Alam A Saudi Pharm J; 2024 Mar; 32(3):101984. PubMed ID: 38384476 [TBL] [Abstract][Full Text] [Related]
13. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments. Soni K; Rizwanullah M; Kohli K Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147 [TBL] [Abstract][Full Text] [Related]
14. Nanostructured lipid carrier-incorporated gel for efficient topical delivery of fluconazole. Patil A; Tuencar V; Gadad A; Dandagi P; Masareddy R Ther Deliv; 2021 Aug; 12(8):565-574. PubMed ID: 34187177 [No Abstract] [Full Text] [Related]
16. Novel Luliconazole Spanlastic Nanocarriers: Development and Characterisation. Marques SM; Chavan DU; Bhide PJ; Joshi M; Kumar L; Shirodkar RK Curr Drug Deliv; 2023; 20(6):792-806. PubMed ID: 35578877 [TBL] [Abstract][Full Text] [Related]
17. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization. Nagaich U; Gulati N Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979 [TBL] [Abstract][Full Text] [Related]
18. Quality by Design Assisted Development of Luliconazole Transethosomes in Gel for the Management of Singh G; Narang RK Assay Drug Dev Technol; 2024 Jan; 22(1):1-17. PubMed ID: 38156818 [TBL] [Abstract][Full Text] [Related]
19. Formulation and Optimization of Topical Solid Lipid Nanoparticles based Gel of Dapsone Using Design of Experiment. Deshkar SS; Bhalerao SG; Jadhav MS; Shirolkar SV Pharm Nanotechnol; 2018; 6(4):264-275. PubMed ID: 30394227 [TBL] [Abstract][Full Text] [Related]
20. An Ex Vivo Evaluation of Moxifloxacin Nanostructured Lipid Carrier Enriched In Situ Gel for Transcorneal Permeation on Goat Cornea. Gade S; Patel KK; Gupta C; Anjum MM; Deepika D; Agrawal AK; Singh S J Pharm Sci; 2019 Sep; 108(9):2905-2916. PubMed ID: 30978345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]